The Medicines and Healthcare products Regulatory Agency has signed a Memorandum of Understanding with its Russian counterpart
The Medicines and Healthcare products Regulatory Agency (MHRA) has signed a Memorandum of Understanding (MoU) with its Russian counterpart; the State Institute of Drugs and Good Practices of the Ministry of Industry and Trade of the Russian Federation.
This agreement will increase collaboration between the two bodies and further enhance cooperation in the field of regulation of medicines.
Dr Sam Atkinson, MHRA’s Director of the Inspection, Enforcement and Standards Division, said: “Working in an increasingly global environment, the sharing of intelligence between medicines regulators is the cornerstone of protecting the health system worldwide.”
The memorandum is designed to encourage cooperation to facilitate information exchange on medicines regulations, safety information and GMP inspections. It is also meant to enhance collaboration on enforcement activities.
Speaking to Sputnik, Nikolay Tsatsyn, Head of the International Cooperation Department for the Russian institute said: “We know that exiting the European Union is quite a complicated and sensitive process. We know it from our colleagues that Great Britain is interested in keeping and enhancing relations with other nations despite Brexit. Therefore, I guess it's essential for Britain as well as for Russia to preserve and strengthen their relations despite all this turbulence.”